Benchmark initiates coverage on Agilon Health (AGL) with a Buy recommendation

Fintel reports that on October 20, 2023, Benchmark initiated coverage of Agilon Health (NYSE: AGL ) purchase recommend.

Analyst price forecasts point to a 51.44% rise

The average one-year price target for Agilon Health as of October 5, 2023 is 29.29. Forecasts range from a low of $21.21 to a high of $43.05. The average price target represents a 51.44% increase from the latest closing price of 19.34.

Check out our ranking of companies with the biggest upside to their price targets.

Agilon Health expects annual revenue to be 3,950MM, an increase of 7.63%. Annual non-GAAP earnings per share are expected to be -0.01.

How is fund sentiment?

There are 518 funds or institutions reporting positions in Agilon Health. This represents an increase of 7 owners from the previous quarter, or an increase of 1.37%.average portfolio weight of all funds Dedicated AGL is 0.31%, a reduction of 26.41%. The total number of shares held by institutions increased by 4.76% in the past three months to reach 538,987K shares. AGL has a put/call ratio of 0.34, indicating a bullish outlook.

What are the other shareholders doing?

Institutional Holdings of AGL/Agilon Health Inc Stock

Clayton, Dubilier & Rice holds 100,000K shares, accounting for 24.66% of the company’s ownership.In previous filings, the company reported owning 194,611K shares, representing reduce 94.61%.The company reduce Its portfolio allocation in AGL increased by 49.22% from the previous quarter.

Capital World Investors holds 51,348K shares, accounting for 12.66% of the company’s equity.In previous filings, the company reported owning 42,436K shares, representing Increase 17.36%.The company reduce Its portfolio allocation in AGL increased by 17.79% from the previous quarter.

Wellington Management Group Llp holds 38,157K shares, accounting for 9.41% of the company’s ownership.In previous filings, the company reported owning 20,346K shares, representing Increase is 46.68%.The company Increase Its portfolio allocation in AGL increased by 828.03% from the previous quarter.

VGHCX – Vanguard Health Care Fund Investor Shares holds 19,043K shares, accounting for 4.70% of the company’s ownership.In previous filings, the company reported owning 14,265K shares, representing Increase 25.09%.The company Increase Its portfolio allocation to AGL increased by 6.84% from the previous quarter.

ANEFX – NEW ECONOMY FUND holds 17,247K shares, accounting for 4.25% of the company’s ownership.In previous filings, the company reported owning 14,503K shares, representing Increase 15.91%.The company Increase Its AGL portfolio allocation increased by 5.40% from the previous quarter.

Aguillon Health Background Information
(This description was provided by the company.)

agilon health is transforming health care by providing community physicians with the resources and expertise they need to innovate how elder care is paid for and delivered. agilon health enables physicians to create their own Medicare-centric global capital business lines. agilon’s comprehensive care model is powered by its purpose-built platform and enabled by a growing national network of like-minded physician partners. With agilon, physicians are freed from the constraints of a fee-for-service reimbursement transaction model and can implement coordinated, team-based care to meet the individual needs of older patients and transition to sustainable, predictable, long-term care. The term business model. The rapid growth in traction of agilon’s platform, partnership model and leading community physician network has allowed the company to expand to 17 local communities with 16 anchor physician groups and a physician network throughout Hawaii in less than five years .

Fintel is one of the most comprehensive investment research platforms for individual investors, traders, financial advisors and small hedge funds.

Our data covers the world, including fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flows, unusual options trades and more. Plus, our exclusive stock picks are powered by advanced, back-tested quantitative models to boost profits.

Click to learn more

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Leave a Comment

Your email address will not be published. Required fields are marked *

%d bloggers like this: